酚妥拉明联合利尿剂治疗对重症肺结核合并肺心病患者心功能指标影响的临床观察研究

Clinical observational study on the effects of phentolamine combined with diuretic treatment on cardiac function indicators in patients with severe pulmonary tuberculosis and pulmonary heart disease

ES评分 0

DOI 10.12208/j.ijcr.20240416
刊名
International Journal of Clinical Research
年,卷(期) 2024, 8(10)
作者
作者单位

宁夏回族自治区第四人民医院 宁夏银川 ;
;

摘要
研究酚妥拉明联合利尿剂治疗对重症肺结核合并肺心病患者心功能指标的影响。方法 选取2021年6月—2023年12月期间在宁夏回族自治区第四人民医院收治的重症肺结核合并肺心病患者160例,随机分为对照组(常规治疗结合利尿剂)和观察组(酚妥拉明联合利尿剂治疗),每组各80例;比较两组的心功能指标、肺功能指标、临床症状改善情况以及凝血功能指标。结果 观察组治疗后的LVEF高于对照组,LVEDD、LVESD均低于对照组,差异显著(P <0.05);观察组治疗后的FVC、FEV1均更高,而PASP、PaCO2均更低(P <0.05);观察组的临床症状所需时间均短于对照组(P <0.05);观察组治疗后的凝血功能指标优于对照组(P <0.05)。结论 重症肺结核合并肺心病患者经过酚妥拉明联合利尿剂治疗后,能显著改善其心功能和肺功能,缩短临床治疗时间,治疗效率显著提高,该联合治疗方案值得临床推广。
Abstract
Objective To study the effect of phentolamine combined with diuretic treatment on cardiac function indicators in patients with severe pulmonary tuberculosis and pulmonary heart disease. Methods 160 patients with severe pulmonary tuberculosis combined with pulmonary heart disease admitted to the Fourth Peoples Hospital of Ningxia Hui Autonomous Region from June 2021 to December 2023 were selected and randomly divided into a control group (conventional treatment combined with diuretics) and an observation group (phentola combined with diuretic treatment), 80 cases in each group; compare the cardiac function indicators, pulmonary function indicators, improvement of clinical symptoms and coagulation function indicators between the two groups. Results After treatment, the LVEF of the observation group was higher than that of the control group, and LVEDD and LVESD were lower than those of the control group, with significant differences (P <0.05); the FVC and FEV1 of the observation group after treatment were both higher, while PASP and PaCO2 were lower ( P <0.05); the time required for clinical symptoms in the observation group was shorter than that in the control group (P <0.05); the coagulation function index of the observation group after treatment was better than that of the control group (P <0.05). Conclusion After treatment with phentolamine combined with diuretics, patients with severe pulmonary tuberculosis and pulmonary heart disease can significantly improve their cardiac and pulmonary functions, shorten clinical treatment time, and significantly improve treatment efficiency. This combined treatment regimen is worthy of clinical promotion.
关键词
酚妥拉明联合利尿剂;重症肺结核合并肺心病;心功能指标;影响
KeyWord
Phentolamine combined with diuretics; Severe pulmonary tuberculosis combined with pulmonary heart disease; Cardiac function indicators; Impact
基金项目
页码 89-91
  • 参考文献
  • 相关文献
  • 引用本文

杨继黎,杨芳,王芳*. 酚妥拉明联合利尿剂治疗对重症肺结核合并肺心病患者心功能指标影响的临床观察研究 [J]. 国际临床研究杂志. 2024; 8; (10). 89 - 91.

  • 文献评论

相关学者

相关机构